Premium
Long‐term follow‐up of patients undergoing percutaneous suprapubic tube drainage after robot‐assisted radical prostatectomy (RARP)
Author(s) -
Sammon Jesse D.,
Trinh QuocDien,
Sukumar Shyam,
Diaz Mireya,
Simone Andrea,
Kaul Sanjeev,
Me Mani
Publication year - 2012
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2011.10786.x
Subject(s) - medicine , prostatectomy , surgery , interquartile range , percutaneous , urinary continence , anastomosis , urinary incontinence , prospective cohort study , prostate cancer , urology , cancer
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add?• Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization of anti‐cholinergic medication. • This study demonstrates the long‐term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.OBJECTIVES• To evaluate the long‐term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot‐assisted radical prostatectomy (RARP).PATIENTS AND METHODS• Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1‐year follow‐up for urinary function. • Functional outcomes were obtained via patient‐administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.RESULTS• Urinary function assessed by patient‐administered questionnaire was analysed at a mean ( sd ) follow‐up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0–1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean ( sd ) follow‐up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure‐specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).CONCLUSIONS• PST placement after RARP is safe and efficacious on long‐term follow‐up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.